2nd Annual Medical Device Biocompatibility Conference

About the Conference

We were happy to welcome our partners, speakers and all participants on our “2nd Annual Medical Device Biocompatibility Conference” took place on the 20th – 21st November 2024 in Berlin Germany!

Conference gathered in Berlin high-level executives from the top companies from the industry. Besides main presentation sessions closed-door business conference will be packed with networking coffee breaks, business networking lunches, dinner, cocktail reception (get together meeting): tie-off atmosphere for all our participants with a great opportunity to discuss the presentations of the first day of the conference, share their opinions and discuss current and upcoming challenges in the industry with their fellow industry colleagues.
Conference will include 20+ innovative presentation sessions from well-known and highly experienced speaking partners and cover a wide spectrum of topics: starting from the regulatory updates, the latest innovations in the industry, technological research, modern manufacturing processes and trends in medical devices biocompatibility market which can help to all participants with current and future challenges and to show how to develop the proactive approach.

Meet some of our speakers

Sandi Schaible

Executive Director/ General Manager, Analytical Chemistry and Regulatory Toxicology

WuXi AppTec GmbH

Paolo Pescio

Senior Scientific Director

Eurofins Medical Device Testing Europe

Erik Vollebregt

Attorney-at-law / Partner

Axon Lawyers

Elena Henderson

Biocompatibility Assessor

Cormica Ltd.

Gert Bos

Executive Director & Partner | CSO | CEO Qserve China

Qserve Group B.V.

To get complete conference program with full list of speaking partners please request the brochure

Request brochure

Key Practical Points

Regulation and legislation updates
Biocompatibility Challenges and Solutions
Understanding ISO 10993-1 and ISO 10993-18 for regulatory compliance
Crafting effective biological evaluation plans and connecting them to overall safety
Exploring novel approaches for extractable/leachable assessment
Managing risks through effective toxicological assessments
Identifying common problems and optimizing biocompatibility testing
Implementing alternative approaches in biocompatibility testing
Evaluating nanomaterials and understanding their implications
Harnessing the power of in vitro methods for cytotoxicity testing
Utilizing reconstructed human epidermis assay for irritation testing.
Staying updated on advancements in sensitization testing
Navigating ADME requirements under MDR and assessing CMR/ED substances
Conducting degradation testing and evaluating its significance
Opportunities for hands-on exercises, working groups, and case studies
Business networking lunches and optional tour and dinner for informal interactions
Gaining insights into regulatory frameworks and compliance requirements
Understanding the legal and regulatory consequences of biocompatibility failures

Who Should Attend

This conference will gather together: CEOs, CTOs, CIOs, COOs, SVPs, VPs, Directors, Global Heads, Heads, Managers, Team Leaders, Specialists, Strategists, Planners and Officers of the following divisions:

Toxicology
Medical Device
Biocompatibility
Analytical Chemistry
Research and Development
Safety and Risk Assessments
Materials Science and Selection
Product and Process Development
Marketing and Business Development
Manufacturing Science and Technology
Quality Assurance and Regulatory Affairs

“2nd Annual Medical Device Biocompatibility Conference”

20th – 21st November 2024 in Berlin Germany took place at our Official Hotel Partner

Novotel Berlin Mitte, address: Fischerinsel 12, 10179, Berlin Germany